| View |
DRP-10661_PI_01.pdf
|
DRP-10661
|
Amoxicillin (As Trihydrate)
|
Vaxman
|
125 mg / 5 mL
|
Powder for Suspension
|
Antibacterial (Penicillin)
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
26 October 2022
|
30 October 2027
|
| View |
DRP-10662_PI_01.pdf
|
DRP-10662
|
AMOXICILLIN (AS TRIHYDRATE)
|
VAXMAN
|
100 mg/mL
|
Powder for Suspension (Oral Drops)
|
ANTIBACTERIAL (PENICILLIN)
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
Renewal
|
13 May 2023
|
03 June 2028
|
| View |
|
DRP-10634
|
Ascorbic Acid + Cholecalciferol (Vitamin D3) + Zinc
|
None
|
500mg (equivalent to 562.43 mg Sodium
Ascorbate)/1,000 IU/10 mg (equivalent to 70 mg Zinc
Gluconate)
|
Capsule
|
Vitamin
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial [OTC]
|
25 October 2021
|
25 October 2026
|
| View |
|
DRP-10663
|
Cefalexin (As Monohydrate)
|
Mefolex
|
250 mg / 5 mL
|
Powder for Suspension
|
-
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
-
|
04 November 2021
|
27 June 2026
|
| View |
|
DRP-9885-01
|
Ascorbic Acid+Zinc
|
Leximin
|
500mg (equivalent to 562.46mg Sodium Ascorbate) /
10mg (equivalent to 70mg Zinc Gluconate)
|
Capsule
|
Vitamin / Mineral
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP
|
09 November 2021
|
25 January 2026
|
| View |
|
DRP-10071-01
|
Cefalexin (as monohydrate)
|
Unbranded
|
250mg/mL
|
Powder for oral suspension
|
Antibacterial ( Cephalosporin)
|
Scott-Edil Advance Research Laboratories &
Education Limited
|
India
|
Renewal
|
02 August 2024
|
15 September 2029
|
| View |
|
DRP-10073-01
|
Cefuroxime (as Axetil)
|
N/A
|
250mg/5mL
|
Powder for Oral suspension
|
Antibacterial (Cephalosporin)
|
Scott-Edil Advance Research Laboratories &
Education Limited
|
India
|
Renewal
|
10 May 2024
|
10 October 2029
|
| View |
|
DRP-2639-04
|
Amlodipine (As Besilate)
|
None
|
5mg
|
Tablet
|
-
|
New Myrex Laboratories, Inc.
|
Philippines
|
-
|
26 October 2021
|
01 June 2025
|
| View |
|
DRP-7448-02
|
Metformin Hydrochloride
|
None
|
500mg
|
Film-Coated Tablet
|
Oral Hypoglycemic
|
New Myrex Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
23 November 2022
|
02 November 2027
|
| View |
|
DRP-9202-01
|
Ascorbic Acid + Zinc + Cholecalciferol (Vitamin D3
|
Immunforte
|
500mg (equivalent to 562.43 mg Sodium Ascorbate)
10 mg (equivalent to 70 mg Zinc Gluconate)
1000 IU per Capsule
|
Capsule
|
Vitamins/Mineral
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial (CLIDP)
|
17 February 2022
|
08 October 2025
|
| View |
|
DRP-10357-01
|
Dexamethasone Phosphate (As Sodium)
|
Dexameds
|
4 mg/mL (8 mg/2mL)
|
Solution for Injection (I.M./I.V.)
|
Corticosteroid (Glucocorticoid)
|
Vesco Pharmaceutical Company Limited
|
Thailand
|
CLIDP
|
05 November 2021
|
15 September 2026
|
| View |
|
DRP-4463-05
|
Carvedilol
|
Zerevedil
|
25 mg
|
Tablet
|
Combined Alpha and Beta-Adrenoceptor Blocker
|
Zim Laboratories Limited
|
India
|
Automatic Renewal
|
12 October 2022
|
04 June 2028
|
| View |
|
DRP-10069-01
|
Cefpodoxime (As Proxetil)
|
None
|
200mg
|
Film-Coated Tablet
|
-
|
Scott-Edil Advance Research Laboratories &
Education Limited
|
India
|
-
|
26 October 2021
|
28 October 2025
|
| View |
|
DRP-10678
|
Ascorbic Acid
|
None
|
500 mg (equivalent to 562.43 mg Sodium Ascorbate)
|
Capsule
|
Vitamins
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
04 November 2021
|
04 November 2026
|
| View |
|
DRP-2821-07
|
Ambroxol Hydrochloride
|
Phlegmcure
|
15 mg/ 5 mL
|
Syrup
|
-
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
-
|
03 November 2021
|
23 December 2025
|
| View |
|
DRP-3400-02
|
Phenylephrine Hydrochloride + Chlorpheniramine Maleate + Paracetamol
|
Nasocure
|
2.5 mg/ 500 mcg/ 125 mg per 5 mL
|
Syrup
|
Decongestant/Antihistamine/Analgesic/Antipyretic
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
Automatic Renewal
|
24 January 2022
|
22 November 2026
|
| View |
|
DR-XY47502
|
Ascorbic Acid + Zinc
|
Zimmunity
|
500 mg (equivalent to 565.50 mg Sodium Ascorbate)
/10 mg (equivalent to 27.5 mg Zinc Sulfate Monohydrate)
|
Capsule
|
-
|
Compact Pharmaceuticals, Corp.
|
Philippines
|
-
|
09 February 2022
|
29 October 2026
|
| View |
|
BRP-040-14
|
Enoxaparin Sodium
|
Dynaxaparin
|
6000 IU anti-Factor Xa (equivalent to 60 mg)/0.6 mL
|
Solution for Injection (SC)
|
-
|
Brawn Laboratories Ltd.
|
India
|
-
|
05 November 2021
|
09 December 2025
|
| View |
|
BRP-041-14
|
Enoxaparin Sodium
|
Dynaxaparin
|
4000 IU anti-Factor Xa (equivalent to 40 mg)/0.4 mL
|
Solution for Injection (SC)
|
Antithrombotic agents
|
Brawn Laboratories Ltd.
|
India
|
Initial (Revalidation) (Reconstruction).
|
31 July 2024
|
09 December 2025
|
| View |
|
BRP-040-12
|
Enoxaparin Sodium
|
Coranox
|
6000 IU anti-Factor Xa (equivalent to 60 mg)/0.6 mL
|
Enoxaparin Sodium
|
-
|
Brawn Laboratories Ltd.
|
India
|
-
|
05 November 2021
|
09 December 2025
|